ABAlexandra S. Balkina

Alexandra S. Balkina

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Alexandra S. Balkina has a total of 32 co-authors. Here are the top co-authors by number of shared publications:

  • Svetlana S. Kurashova

    Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences (Institute of Poliomyelitis)

    5 shared publications
  • Aydar A. Ishmukhametov

    Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences (Institute of Poliomyelitis), Moscow 108819, Russia

    4 shared publications
  • Evgeniy A. Tkachenko

    Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences, Institute of Poliomyelitis, Moscow 108819, Russia

    4 shared publications
  • Rostislav Teodorovich

    Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences (Institute of Poliomyelitis)

    4 shared publications
  • Alla V. Belyakova

    Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences (Institute of Poliomyelitis)

    3 shared publications
  • Maria S. Egorova

    Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences (Institute of Poliomyelitis)

    3 shared publications

Latest Publications

  • Open Access

    Immunogenicity of candidate HFRS vaccines based on guinea pig models

    by Svetlana S. Kurashova, Maria S. Egorova, Anna N. Vetrova, Rostislav D. Teodorovich, Alexandra S. Balkina, Alla V. Belyakova, Tamara K. Dzagurova, Aydar A. Ishmukhametov, Ишмухаметов Айдар Айратович

    Introduction. Cases of hemorrhagic fever with renal syndrome (HFRS) have increased over the past ten years, including in regions previously non-endemic for HFRS. Approximately 98% of all cases in Russia are associated with Puumala hantavirus, while only about 2% of sporadic cases are caused by Hantaan, Amur, Seoul, Kurkino and Sochi hantaviruses. The main HFRS foci are located in the European part of Russia. In endemic areas, the risk of infection exists for all population groups, especially military personnel and workers in the forestry and agricultural sectors. The etiotropic therapy absence can be solved only through vaccination. However, licensed vaccines based on Hantaan or Seoul hantaviruses do not provide protection against Puumala hantavirus, for which no vaccines currently exist worldwide. An experimental vaccine (EV) for the prevention of HFRS, based on Puumala and Hantaan hantaviruses, has been developed at the Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of the Russian Academy of Sciences (Institute of Poliomyelitis). The aim of the study is to determine the EV immunogenicity against HFRS in a guinea pig model using various immunisation schedules. Materials and methods. The induction of neutralising antibodies (NAb) was assessed in the blood serum of guinea pigs following immunisation with mono- and bivalent EV by means of a neutralisation assay based on 50% suppression of focus-forming units in Vero E6 cell culture. The results indicate the formation of a humoral immune response following EV immunisations. Immunogen administration induced the NAb production up to peak values followed by a decrease after certain intervals. Repeated EV administration showed similar NAb dynamics with prolonged circulation. Three variants involving double immunisation and a subsequent booster after one year were prioritised for clinical trials (0, 150, 300; 0, 14, 182, 364; 0, 30, 364). Conclusion. This study indicates the development of a persistent and intense immune response, the strength of which depended on the EV immunisation schedule. The optimal timing for immunogen administration has been determined. The results of this study will be the basis for subsequent clinical trials of hantavirus vaccines.


  • Open Access

    Epidemiological Analysis of the Incidence of Hemorrhagic Fever with Renal Syndrome and Tick-Borne Encephalitis in the Russian Federation

    by T. K. Dzagurova, E. A. Tkachenko, Д. В. Транквилевский, N. M. Kolyasnikova, R. D. Teodorovich, S. S. Kurashova, M. F. Vorovich, P. E. Tkachenko, A. S. Balkina, M. S. Egorova, et al.

    Relevance. Hemorrhagic fever with renal syndrome (HFRS) and tick-borne encephalitis (TBE) are the most common natural focal diseases of viral etiology in Russia. The medical and social significance of these two infections is determined by the extensive foci of their spread, high annual morbidity rates, and the presence of severe forms of the disease can lead to permanent disability and even death. Aim. To assess the current epidemiological situation of HFRS and TBE in the Russian Federation. Conclusions. Over 23 years (from 2000 to 2022), 164,582 cases of HFRS were identified in Russia with an average annual rate of 4.9 cases per 100 thousand population, as well as 71,579 cases of TBE with an average annual rate of 2.5 cases per 100 thousand population; 668 (0.4%) and 1136 (1.6%) deaths from HFRS and TBE, respectively; 4030 (2.5%) and 9414 (13%) children under the age of 14 years among patients with HFRS and TBE, respectively. The incidence of HFRS and TBE per 100 thousand population of Russia was higher among rural residents than among urban residents. Most cases of HFRS were registered in the autumn-winter period, and TBE – at the end of June – the first half of July. Of the 85 administrative regions of Russia, cases of HFRS and TBE are registered in 42, in 18 – only HFRS, in 13 – only TBE, and in 12 regions no clinically diagnosed cases of HFRS and TBE have been identified.


  • Open Access

    Physical and Chemical Inactivators Evaluation for the Puumala Virus Vaccine Technology Development

    by S. S. Kurashova, M. S. Egorova, M. V. Balovneva, A. N. Vetrova, A. S. Balkina, R. D. Teodorovich, V. G. Petrov, T. K. Dzagurova, E. A. Tkachenko

    Relevance. Hemorrhagic fever with renal syndrome (HFRS) is leading among natural focal human diseases in Russia, the causative agents of which - orthohantaviruses - belong to the order Bunyavirales, family Hantaviridae. More than 98% of HFRS cases in Russia are caused by the Puumala virus. It is a serious zoonosis for which there is still no specific treatment. The WHO has not approved a vaccine. The aim of this study was to investigate the effect of formaldehyde, β-propiolactone, hydrogen peroxide, ultraviolet rays, gamma irradiation and thermal inactivation on the immunogenic activity of inactivated vaccine preparations against HFRS Materials and methods. To achieve this aim, experimental vaccine preparations based on the PUU-TKD/VERO strain of Puumala virus were prepared and inactivated using the methods described above. The time intervals required for complete inactivation of the virus were determined, and the effects of the inactivators on viral RNA and immunogenic activity of the vaccine preparations were evaluated in BALB/c mouse and Syrian hamster models. Results. According to our results, vaccine preparations inactivated by different chemical and physical methods, which differ significantly in the mechanism of the mechanism of interaction with the virus, show no significant differences in immunogenic activity, except for thermal inactivation. Conclusion. A certain advantage of β-propiolactone is the short virus inactivation time, its complete degradation into non-toxic compounds within a few hours, and the reduction of total protein content after sterilization filtration, which is probably due to less aggregation of virus particles and cellular proteins


  • Open Access

    Applied and Theoretical Aspects of the Ecology of Pathogens of Hemorrhagic Fever with Renal Syndrome and Tick-Borne Encephalitis

    by E. A. Tkachenko, T. K. Dzagurova, Д. В. Транквилевский, N. M. Kolyasnikova, Yu. V. Popova, R. D. Teodorovich, M. F. Vorovich, S. S. Kurashova, P. E. Tkachenko, A. S. Balkina, et al.

    Relevance. Hemorrhagic fever with renal syndrome (HFRS) and tick-borne encephalitis (TBE) are the most common natural focal diseases of viral etiology In Russia. The medical and social significance of these two infections is determined by the extensive fociof their spread, high annual morbidity rates in the population, and the possibility of developing severe forms of the disease leading to permanent disability and death. The causative agents of HFRS In Russia are 6 types of hantaviruses Hantaan, Amur, Seoul, Puumala, Kurkino and Sochi, which, immunologically and genetically significantly different from each other, support their existence in nature through six different species of small mammals, which are sources of infection in humans. TBE virus strains that cause disease in humans belong to five phylogenetically distinct subtypes, including: Far Eastern, European, Siberian, “178-79” and Baikal. Aim. Analysis of the role of small mammals and ticks in the ecology of HFRS and TBE pathogens. Conclusions. Small mammals retain and transmit hantaviruses to uninfected animals and ticks. At the same time, ticks retain and transmit to ticks and mammals not only the TBE virus, but also hantaviruses. Despite the taxonomic difference between the viruses that cause HFRS and TBE, some of their ecological properties are similar.


  • Open Access

    Real-time PCR assay development for the control of vaccine against hemorrhagic fever with renal syndrome

    by M. S. Egorova, S. S. Kurashova, A. A. Ishmukhametov, M. V. Balovneva, A. A. Deviatkin, M. V. Safonova, S. V. Ozherelkov, Yu. Kh. Khapchaev, A. S. Balkina, A. V. Belyakova, et al.

    Introduction. Hemorrhagic fever with renal syndrome (HFRS) holds a leading place among natural focal human diseases in Russian Federation. There is no etiotropic therapy for the disease now. The vaccine prophylaxis is the most effective method to control this infection. The main criteria for inactivated vaccines evaluation are its immunogenicity and specific activity.The study purposes were to develop a sensitive and specific real-time PCR method for viral RNA quantification in the inactivated vaccine and to study the correlation between the viral RNA amount and vaccine immunogenicity.Material and methods. L-segment fragments of the Puumala, Hantaan, and Sochi vaccine strains were selected as diagnostic targets for oligonucleotides and fluorescent probes. The immunogenicity of experimental vaccines was determined by the induction of neutralizing antibodies in BALB/c mice.Results. A highly specific, sensitive and reproducible real-time PCR method has been developed. The analytical sensitivity was 1.24 ± 1.5 x 102 copies/ml for Puumala virus; 1.16 ± 1.4 * 102 copies/ml for Hantaan; 1.32 ± 1.8 * 102 copies/ ml for Sochi, with a virus content of 1.5 ± 0.5 lg FFU/ml; 1.8 ± 0.5 lg FFU/ml and 2.2 ± 0.5 lg FFU/ml, respectively. The viral RNA amount in experimental vaccine preparations inactivated with β-propiolactone was proportional to the neutralizing antibodies titer observed in mice following the immunization.Discussion. It was found that different virus inactivators differently affects the detected viral RNA amount, but not the vaccine immunogenicity, which indicates the same degree of the immunogenic proteins damage. The direct relationship between the viral RNA copy number and vaccine immunogenicity makes it possible to use this criterion for vaccine dosage preparation.Conclusion. The developed method for viral RNA quantification is a promising tool for the specific activity control of the HFRS vaccine.


  • Interaction of the Water-Soluble Protein Aprotinin with Liposomes: Gel-Filtration, Turbidity Studies, and31P NMR Studies

    by O. Tiourina, T. Sharf, A. Balkina, M. Ollivon, A. Selischeva, G. Sorokoumova, N. Larionova

    The interactions of a water-soluble nonmembrane protein aprotinin with multilamellar vesicles (MLV) and small unilamellar vesicles (SUV) from soybean phospholipids were studied using Sephadex G-75 gel chromatography combined with different methods of the analysis of the eluate fractions (fluorescence, light-scattering, turbidity; 31P NMR spectroscopy). The composition of the liposomes mainly containing soybean phosphatidylcholine (PC) was varied by the addition of phosphatidylethanolamine (PE), phosphatidylinositol (PI) and lyso-phosphatidylcholine (lyso-PC). To evaluate the lipid-protein interactions, the amount of aprotinin in the MLV–aprotinin complexes was determined. Lipid–protein interactions were found to strongly depend on the liposome composition, medium pH and ionic strength. These dependencies point to the electrostatic nature of the aprotinin-lipid interactions. 31P NMR spectroscopy of the MLV–aprotinin complexes indicated that aprotinin influences the phospholipid structure in MLV at ...